Gene Editing's 2026 Reality Check: Billion-Dollar Bets and the AI HorizonGlobal Report·Jul 22 at 04:17 AMVRTX-1.01%CRSP-2.74%
ProQR Therapeutics director Bart Filius buys $257,925 of common sharesPUBT·Jul 21 at 07:00 AMPRQR-1.26%
ProQR Therapeutics (NASDAQ:PRQR) Stock Passes Above 50-Day Moving Average - Here's WhyMarket Beat·Jul 21 at 02:40 AMPRQR-1.26%
ON Semiconductor To Rally More Than 15%? Here Are 10 Top Analyst Forecasts For Fridaybenzinga_article·Jun 26 at 08:15 AMMEI+6.29%DRI-0.73%
Pre-market hot trades in US stocks: ProQR Therap down 9.78% pre-market; Americas Car Mart down 8.46% pre-marketPrice Alert·Jun 26 at 06:12 AMPRQR-1.26%CRMT-5.96%
ProQR sells 5,100,780 shares to Lilly in $9.2 million private placement at $1.81 eachPUBT·Jun 26 at 05:03 AMLLY-3.59%PRQR-1.26%
ProQR Prices $50.0 Million Underwritten Registered Direct Offering and Concurrent Private Placement | PRQR Stock NewsStockTitan·Jun 24 at 09:35 PMPRQR-1.26%LLY-3.59%
